Revolutionizing the Future of Cancer Treatment with Photoactivated Chemotherapy

We are developing the next generation of light-activated cancer therapies to deliver powerful anti-tumor effects with unprecedented precision and safety.

Contact Us

About

LITE Therapeutics

LITE Therapeutics is a French biotech company created in 2024 developing a patent-protected, next-generation photoactivated chemotherapy platform to treat cancers with high unmet medical needs.

Diagram illustrating a process involving a prodrug activated by light and a catalyst, leading to the production of photoproducts that interact with proteins and DNA, ultimately causing cancer cell death. PACT, photoactivated chemotherapy
About Us

Our

Solution

Our solution uses targeted photoactivated chemotherapy to attack tumors more effectively and safely than conventional chemotherapies.

A black outline of a hand holding a circle with a medical cross symbol inside. less toxicity
Medical graphic with a target, syringe, medical cross, and upward trending graph. targeted treatment

Reduced Systemic Toxicity

Light-Activated Treatment,

Light-Guided Release for

Illustration of plant cells showing oxygen levels, with darker areas indicating hypoxia and lighter areas indicating normoxia. treatment working in hypoxia, non-oxygen dependant mechanism of activation

Precise Tumor Targeting

Works in Hypoxic Tumors

Oxygen-Independent Activation,

Learn More